watsapp-num
United States Overview

Regulatory Solutions for United States

The United States is the world's premier hub for innovation, investment, and growth in medicinal products, medical devices, and advanced healthcare technologies, offering unparalleled opportunities for foreign manufacturers.

The United States Food and Drug Administration (FDA) enforces rigorous, science-based standards for product safety, efficacy, and quality through pathways such as INDs, NDAs, BLAs, 510(k), PMA, De Novo, and more. Navigating FDA regulations, premarket requirements, inspections, and post-market obligations requires deep expertise amid a constantly evolving landscape. MedWisdom LifeScience specializes in guiding foreign manufacturers through these complexities, providing strategic regulatory support, registration assistance, compliance solutions, and ongoing partnership to ensure products meet the highest FDA standards, accelerate market entry, and achieve long-term success in this highly competitive and rewarding market.

Get USA Compliance Support
United States Flag

Medwisdom Lifescience Offerings in United States

Quality Assurance and Quality Control (QA/QC)

Support for cGMP compliance, FDA QSR/QMSR implementation, quality system audits, CAPA management, and preparation for FDA inspections.

Risk Management and Risk Assessment

Development of ISO 14971-compliant risk management files, hazard analysis, risk-benefit evaluations, and FDA-aligned risk mitigation plans for drugs and devices.

Clinical Trial Regulatory Support

IND/CTN submissions, FDA meeting preparation (Pre-IND, End-of-Phase, Type C), protocol development support, and clinical trial regulatory compliance in the US.

Post-Market Surveillance

PMS/PMSR plans, MDR/MDV reporting, recall management, trend analysis, and compliance with FDA post-market requirements for devices and drugs.

Pharmacovigilance and Drug Safety Reporting

US QPPV/local contact support, adverse event reporting (FAERS), IND safety reports, PADER/PSUR/PBRER submissions, and signal detection for US market.

Regulatory Training and Education

Customized FDA compliance training, workshops on 21 CFR Parts 11/210/211/820/803/806, eCTD submissions, and ongoing education for teams and partners.

Regulatory Strategy Development

Tailored regulatory roadmaps, pathway selection (510(k), PMA, NDA, ANDA, De Novo), breakthrough therapy/fast track designation support, and strategic planning for US market entry.

Health Authority Interactions and Meetings

Preparation and facilitation of FDA meetings (Pre-Submission, Type A/B/C, Advisory Committee), query responses, and direct liaison with FDA reviewers.

Ready to Enter the US Market?

Partner with Medwisdom for expert, strategic, and fully compliant regulatory support in the United States — from FDA strategy development and clinical trial support to pharmacovigilance, quality systems, and sustained market leadership.

Contact Our USA Regulatory Experts